Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HSV-1”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Early research (Phase 1)Looking for participantsNCT07076498
What this trial is testing

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

Who this might be right for
Glioma
M.D. Anderson Cancer Center 20
Very early researchUnknownNCT06135844
What this trial is testing

Hand Sanitizer Use for Herpes Simplex Virus-1

Who this might be right for
VirusHSV-1Herpes Simplex 1+1 more
Leciel Bono 20
Very early researchUnknownNCT05860374
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors

Who this might be right for
SarcomaCarcinomaBreast Cancer+6 more
Shanghai Yunying Medical Technology 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07032649
What this trial is testing

Evaluating Benzoyl Peroxide for Preventing Recurrence of HSV-1 Outbreaks With Rescue Crossover Option

Who this might be right for
HSV
Greg Bew 100
Large-scale testing (Phase 3)Study completedNCT00057330
What this trial is testing

HerpeVac Trial for Young Women

Who this might be right for
Herpes Simplex Infection
GlaxoSmithKline 8,323
Not applicableLooking for participantsNCT04917887
What this trial is testing

Long-Term Follow-up Protocol

Who this might be right for
Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis BullosaDominant Dystrophic Epidermolysis Bullosa
Krystal Biotech, Inc. 50
Not applicableStudy completedNCT01112956
What this trial is testing

Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2

Who this might be right for
Genital Herpes
Centers for Disease Control and Prevention 2,500
Early research (Phase 1)Looking for participantsNCT06914479
What this trial is testing

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

Who this might be right for
Recurrent Diffuse Hemispheric Glioma, H3 G34-MutantRecurrent Malignant Brain NeoplasmResectable Brain Neoplasm
University of Michigan Rogel Cancer Center 11
Not applicableAvailableNCT05844436
What this trial is testing

Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2

Who this might be right for
HSV
AiCuris Anti-infective Cures AG
Not applicableStudy completedNCT04664127
What this trial is testing

Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer Kagocel

Who this might be right for
HerpesHerpes SimplexHerpes Oral+2 more
Nearmedic Plus LLC 45
Not applicableStudy completedNCT02270099
What this trial is testing

Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects

Who this might be right for
Herpes Simplex Infections
Hologic, Inc. 839
Early research (Phase 1)Active Not RecruitingNCT05432583
What this trial is testing

A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions

Who this might be right for
Genital Herpes Simplex Type 2
BioNTech SE 318
Testing effectiveness (Phase 2)Study completedNCT03536143
What this trial is testing

A Phase I/II Study of KB103, a Topical HSV1-COL7, on DEB Patients

Who this might be right for
Dystrophic Epidermolysis Bullosa
Krystal Biotech, Inc. 12
Very early researchUnknownNCT05830240
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer

Who this might be right for
Head and Neck CancerEsophageal CancerOtorhinolaryngologic Neoplasms+4 more
Shanghai Yunying Medical Technology 9
Testing effectiveness (Phase 2)Study completedNCT01477879
What this trial is testing

Hsv 1 and 2 Gowey Protocol Versus Placebo

Who this might be right for
Herpes
Naturopaths International 33
Very early researchUnknownNCT05886075
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors

Who this might be right for
Lung CancerBronchial CancerNon Small Cell Lung Cancer+9 more
Shanghai Yunying Medical Technology 24
Large-scale testing (Phase 3)Looking for participantsNCT06581406
What this trial is testing

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal Melanoma
Replimune, Inc. 280
Not applicableWithdrawnNCT01059084
What this trial is testing

An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons

Who this might be right for
HIVHIV Infections
University of Washington
Testing effectiveness (Phase 2)Study completedNCT03153085
What this trial is testing

Combination with TBI-1401(HF10) and Ipilimumab in Japanese Patients with Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Takara Bio Inc. 28
Testing effectiveness (Phase 2)UnknownNCT05735158
What this trial is testing

Topical KB105 for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI)

Who this might be right for
Autosomal Recessive Ichthyosis
Krystal Biotech, Inc. 15
Next Page